Premium Delafloxacin API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Delafloxacin (Active Pharmaceutical Ingredient) (Also searched as Delafloxican)

Supplier / Distributor: Morgan

Therapeutic Category: Fluoroquinolone Antibacterial

Indications: Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Community-Acquired Bacterial Pneumonia (CABP)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Delafloxacin distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Delafloxacin is a highly potent, broad-spectrum small-molecule Active Pharmaceutical Ingredient (API). In antimicrobial pharmacology, it is classified as a novel anionic fluoroquinolone. For pharmaceutical manufacturers expanding their infectious disease portfolios, this API provides a critical mechanism for targeting resistant bacterial strains, including Methicillin-resistant Staphylococcus aureus (MRSA).

Unlike older generations of fluoroquinolones that are zwitterionic, Delafloxacin lacks a basic protonatable group, giving it an anionic character at neutral pH. This specific chemical structure allows the molecule to exhibit a marked increase in antibacterial activity within acidic environments—such as the localized acidic conditions commonly found in abscesses and infected skin lesions.

At the cellular level, the API exerts its bactericidal effect by competitively inhibiting two essential bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are required for bacterial DNA replication, transcription, repair, and recombination. By disrupting this process, the API halts bacterial proliferation. Because it targets two distinct enzymes simultaneously, the mutation frequency leading to resistance is significantly lower compared to single-target antibiotics.

For pharmaceutical formulation scientists, integrating this API enables the development of versatile, high-efficacy antimicrobial therapeutics. In commercial manufacturing, this active ingredient is standardly formulated into 450 mg oral solid tablets and 300 mg lyophilized powder for intravenous (IV) infusion.

Sourcing Delafloxacin in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced antimicrobial formulations requires a highly resilient and traceable raw material pipeline. Procuring specialty broad-spectrum APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing Delafloxican Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard pilot batch or are scaling up a high-volume Delafloxican api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during blending, tableting, and lyophilization processes.

Technical Specifications for QA & R&D

The Delafloxacin API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• CAS Number: 189279-58-1 (Free Acid)
• Appearance: White to light yellow crystalline solid powder
• Molecular Formula: C20H17ClF3N5O4
• Molecular Weight: 459.83 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers of varying pH are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

While Delafloxacin does not carry severe teratogenic profiles, it is a highly active broad-spectrum antimicrobial compound. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel and prevent cross-contamination.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers, as fluoroquinolones are inherently susceptible to photodegradation. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent degradation and maintain structural integrity.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and compounding stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure weighing booths.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.